Gastrointestinal complications of pelvic radiotherapy: are they of any importance?
- PMID: 16009675
- PMCID: PMC1774900
- DOI: 10.1136/gut.2004.062596
Gastrointestinal complications of pelvic radiotherapy: are they of any importance?
Abstract
Radiation induced bowel damage affects 6000 individuals annually in the UK, with a negative impact on quality of life. Our understanding of how to treat these patients is dismally lacking an evidence base. Fibrosis seems to be the unifying underlying cause for most symptoms. Progress in understanding the development and treatment of fibrosis in these patients might have important consequences for patients with other causes of fibrosis in the gastrointestinal tract.
Comment in
-
Treatment of local ischaemia: another promising approach for gastrointestinal complications of pelvic radiotherapy.Gut. 2006 Aug;55(8):1209. Gut. 2006. PMID: 16849354 Free PMC article. No abstract available.
References
-
- Rubin G, Hungin A, Kelly P, et al. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000;14:1553–9. - PubMed
-
- UKCCCR Anal Cancer Trial Working Party, UK Co-ordinating Committee on Cancer Research. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996;19:1049–54. - PubMed
-
- Thomas G. Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin Radiat Oncol 2000;10:44–50. - PubMed
-
- Andreyev HJN, Amin Z, Blake P, et al. GI symptoms developing after pelvic radiotherapy require gastroenterological review but is that happening in the UK? Clin Oncol 2003;15:S12.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources